Meiji Yasuda Life Insurance Co lessened its holdings in shares of Zoetis Inc (NYSE:ZTS) by 13.7% during the first quarter, HoldingsChannel.com reports. The firm owned 10,523 shares of the company’s stock after selling 1,677 shares during the quarter. Meiji Yasuda Life Insurance Co’s holdings in Zoetis were worth $1,059,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the stock. Louisiana State Employees Retirement System boosted its position in Zoetis by 0.4% during the 1st quarter. Louisiana State Employees Retirement System now owns 25,300 shares of the company’s stock valued at $2,547,000 after acquiring an additional 100 shares in the last quarter. Abbrea Capital LLC boosted its position in Zoetis by 2.9% during the 1st quarter. Abbrea Capital LLC now owns 3,530 shares of the company’s stock valued at $355,000 after acquiring an additional 100 shares in the last quarter. Eukles Asset Management boosted its position in Zoetis by 0.7% during the 1st quarter. Eukles Asset Management now owns 14,241 shares of the company’s stock valued at $1,434,000 after acquiring an additional 101 shares in the last quarter. Mid Atlantic Financial Management Inc. ADV boosted its position in Zoetis by 2.4% during the 1st quarter. Mid Atlantic Financial Management Inc. ADV now owns 4,489 shares of the company’s stock valued at $452,000 after acquiring an additional 104 shares in the last quarter. Finally, Stratos Wealth Advisors LLC boosted its position in Zoetis by 2.4% during the 1st quarter. Stratos Wealth Advisors LLC now owns 4,673 shares of the company’s stock valued at $470,000 after acquiring an additional 111 shares in the last quarter. Institutional investors own 90.30% of the company’s stock.
ZTS has been the topic of a number of analyst reports. Barclays initiated coverage on Zoetis in a research report on Tuesday. They issued an “overweight” rating and a $120.00 price target on the stock. Zacks Investment Research cut Zoetis from a “buy” rating to a “hold” rating in a research report on Monday, May 6th. Gabelli cut Zoetis from a “buy” rating to a “hold” rating and set a $108.00 price target on the stock. in a research report on Thursday, May 2nd. They noted that the move was a valuation call. Guggenheim initiated coverage on Zoetis in a research report on Thursday, May 23rd. They issued a “buy” rating and a $114.00 price target on the stock. Finally, Credit Suisse Group boosted their price target on Zoetis from $102.00 to $112.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 2nd. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $105.00.
ZTS stock traded up $1.29 during midday trading on Wednesday, hitting $111.45. The company’s stock had a trading volume of 1,010,743 shares, compared to its average volume of 2,247,393. The stock has a market capitalization of $52.68 billion, a PE ratio of 35.61, a price-to-earnings-growth ratio of 2.75 and a beta of 0.87. Zoetis Inc has a 12 month low of $78.90 and a 12 month high of $111.66. The company has a current ratio of 4.05, a quick ratio of 2.79 and a debt-to-equity ratio of 2.84.
Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.09. The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Zoetis had a return on equity of 73.66% and a net margin of 23.47%. The firm’s quarterly revenue was up 6.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 EPS. On average, research analysts predict that Zoetis Inc will post 3.48 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Friday, July 19th will be given a $0.164 dividend. The ex-dividend date of this dividend is Thursday, July 18th. This represents a $0.66 annualized dividend and a yield of 0.59%. Zoetis’s dividend payout ratio (DPR) is presently 21.09%.
In other Zoetis news, insider Roxanne Lagano sold 2,000 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $101.89, for a total transaction of $203,780.00. Following the completion of the sale, the insider now directly owns 30,727 shares in the company, valued at approximately $3,130,774.03. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Clinton A. Jr. Lewis sold 6,125 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $96.54, for a total transaction of $591,307.50. Following the sale, the insider now owns 57,042 shares of the company’s stock, valued at $5,506,834.68. The disclosure for this sale can be found here. Insiders sold a total of 76,716 shares of company stock worth $7,805,856 over the last ninety days. 0.29% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “Zoetis Inc (NYSE:ZTS) Shares Sold by Meiji Yasuda Life Insurance Co” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2019/06/12/zoetis-inc-nysezts-shares-sold-by-meiji-yasuda-life-insurance-co.html.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Recommended Story: What is a Special Dividend?
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.